Voyager Therapeutics's total assets for Q4 2025 were $252.28M, a decrease of -12.50% from the previous quarter. VYGR total liabilities were $56.20M for the fiscal quarter, a -17.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.